Novozymes
This person does not yet have a bio.Content by Novozymes
| 5 min read
In recent years, significant work has been dedicated to
studying the half-life of drugs, and while researchers have been successful in lengthening the half-life of proteins and peptides, they have yet to find a
way to tailor the pharmacokinetics of certain drugs to specific medical needs.”
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Journeying through cells' spatial dimensions
Spatial biology adds a new layer of knowledge to unsolved biological questions.
A Technology Guide for AI-Enabled Drug Discovery
Learn practical strategies for using artificial intelligence to find the best drug candidate.
Achieving bioanalytical precision and control
Advanced LIMS software helps researchers reliably manage complex bioanalytical workflows and data.
